GlassScriptPhysician profile
Kyle Popp
NPI 1417608316
$955.54
in general payments reported to CMS, 2019-2025
13 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $229 · 2024: $313 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.02 | 2022-2025 | |
| Novo Nordisk INC | $126.91 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Verrica Pharmaceuticals INC. | $104.31 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $87.48 | 2022-2025 | Shingrix, Arexvy, Boostrix |
| Dexcom, INC. | $81.17 | 2023-2025 | Dexcom G6 Transmitter |
| Neurocrine Biosciences, INC. | $78.09 | 2022 | |
| Pfizer INC. | $43.59 | 2022-2023 | |
| Insmed, INC. | $26.95 | 2025 | Brinsupri, Arikayce |
| Eisai INC. | $22.57 | 2024 | |
| Lilly USA, LLC | $21.43 | 2023 | Jardiance |
| Phathom Pharmaceuticals, INC. | $20.15 | 2024 | Voquezna |
| Collegium Pharmaceutical, INC. | $19.68 | 2025 | Jornay Pm |
| Seqirus USA INC | $17.19 | 2025 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Popp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.